Bharat Biotech International Limited - Product Pipeline Review

Global Markets Direct’s, ‘Bharat Biotech International Limited - Product Pipeline Review - 2016’, provides an overview of the Bharat Biotech International Limited’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Bharat Biotech International Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Bharat Biotech International Limited

The report provides overview of Bharat Biotech International Limited including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Bharat Biotech International Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Bharat Biotech International Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Bharat Biotech International Limited’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Bharat Biotech International Limited

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Bharat Biotech International Limited’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Bharat Biotech International Limited Snapshot 6

Bharat Biotech International Limited ...

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Bharat Biotech International Limited Snapshot 6

Bharat Biotech International Limited Overview 6

Key Information 6

Key Facts 6

Bharat Biotech International Limited - Research and Development Overview 7

Key Therapeutic Areas 7

Bharat Biotech International Limited - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Bharat Biotech International Limited - Pipeline Products Glance 12

Bharat Biotech International Limited - Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Bharat Biotech International Limited - Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Bharat Biotech International Limited - Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

Bharat Biotech International Limited - Drug Profiles 16

THR-100 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

lysostaphin 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

chikungunya vaccine 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

human serum albumin (recombinant) 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

malaria vaccine 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Salmonella [serotypes typhimurium, enteritidis] vaccine 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Staphylococcus aureus vaccine 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Zika virus vaccine 1 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

human papillomavirus vaccine 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

pertussis (acellular) vaccine 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

polio vaccine 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Salmonella paratyphi vaccine 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

tetanus vaccine 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Zika virus vaccine 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Bharat Biotech International Limited - Pipeline Analysis 31

Bharat Biotech International Limited - Pipeline Products by Target 31

Bharat Biotech International Limited - Pipeline Products by Route of Administration 32

Bharat Biotech International Limited - Pipeline Products by Molecule Type 33

Bharat Biotech International Limited - Pipeline Products by Mechanism of Action 34

Bharat Biotech International Limited - Recent Pipeline Updates 35

Bharat Biotech International Limited - Dormant Projects 36

Bharat Biotech International Limited - Locations And Subsidiaries 37

Head Office 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

List of Tables

List of Tables

Bharat Biotech International Limited, Key Information 6

Bharat Biotech International Limited, Key Facts 6

Bharat Biotech International Limited - Pipeline by Indication, ...

List of Tables

Bharat Biotech International Limited, Key Information 6

Bharat Biotech International Limited, Key Facts 6

Bharat Biotech International Limited - Pipeline by Indication, 2016 9

Bharat Biotech International Limited - Pipeline by Stage of Development, 2016 10

Bharat Biotech International Limited - Monotherapy Products in Pipeline, 2016 11

Bharat Biotech International Limited - Phase III, 2016 12

Bharat Biotech International Limited - Phase II, 2016 13

Bharat Biotech International Limited - Preclinical, 2016 14

Bharat Biotech International Limited - Discovery, 2016 15

Bharat Biotech International Limited - Pipeline by Target, 2016 31

Bharat Biotech International Limited - Pipeline by Route of Administration, 2016 32

Bharat Biotech International Limited - Pipeline by Molecule Type, 2016 33

Bharat Biotech International Limited - Pipeline Products by Mechanism of Action, 2016 34

Bharat Biotech International Limited - Recent Pipeline Updates, 2016 35

Bharat Biotech International Limited - Dormant Developmental Projects,2016 36

List of Figures

List of Figures

Bharat Biotech International Limited - Pipeline by Top 10 Indication, 2016 8

Bharat Biotech International Limited - Pipeline by Stage of Development, ...

List of Figures

Bharat Biotech International Limited - Pipeline by Top 10 Indication, 2016 8

Bharat Biotech International Limited - Pipeline by Stage of Development, 2016 10

Bharat Biotech International Limited - Monotherapy Products in Pipeline, 2016 11

Bharat Biotech International Limited - Pipeline by Target, 2016 31

Bharat Biotech International Limited - Pipeline by Route of Administration, 2016 32

Bharat Biotech International Limited - Pipeline by Molecule Type, 2016 33

Bharat Biotech International Limited - Pipeline Products by Mechanism of Action, 2016 34

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports